Skip to main content

Advertisement

Springer Nature Link
Log in

Mitomycin

Clinical Applications in Ophthalmic Practice

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Mitomycin (mitomycin C; MMC) is an antibiotic isolated from Streptomyces caespitosus. The drug is a bioreductive alkylating agent that undergoes metabolic reductive activation, and has various oxygen tension-dependent cytotoxic effects on cells, including the cross-linking of DNA. It is widely used systemically for the treatment of malignancies, and has gained popularity as topical adjunctive therapy in ocular and adnexal surgery over the past 2 decades.

In ophthalmic medicine, it is principally used to inhibit the wound healing response and reduce scarring of surgically fashioned ostia. Hence, it has been used as adjunctive therapy in various ocular surgeries, such as glaucoma filtering surgeries, dacryocystorhinostomy, corneal refractive surgery and surgeries for ocular cicatrisation. In addition, it has been used as an adjunct in the surgical management of pterygia, ocular surface squamous neoplasia, primary acquired melanosis with atypia and conjunctival melanoma. In many of these surgeries and ophthalmic pathologies, MMC showed a significant beneficial effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Table IV
Table V
Fig. 1
Table VI
Table VII
Table VIII
Table IX

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. Verweij J, Pinedo HM. Mitomycin C: mechanism of action, usefulness and limitations. Anticancer Drugs 1990; 1(1): 5–13

    Article  PubMed  CAS  Google Scholar 

  2. Reddy MV, Randerath K. 32P-analysis of DNA adducts in somatic and reproductive tissues of rats treated with the anticancer antibiotic, mitomycin C. Mutat Res 1987; 179(1): 75–88

    Article  PubMed  CAS  Google Scholar 

  3. Lown JW. The molecular mechanism of action of the mitomycins. In: Carter SK, Crooke ST, eds. Mitomycin: current status and new developments. New York: Academic Press, 1979: 243–51

    Google Scholar 

  4. Jampel HD. Effect of brief exposure of mitomycin C on viability and proliferation of cultured human Tenon’s capsule fibroblasts. Ophthalmology 1992; 99: 1471–6

    PubMed  CAS  Google Scholar 

  5. Crowston JG, Akbar AN, Constable PH, et al. Antimetabolite-induced apoptosis in Tenon’s capsule fibroblasts. Invest Ophthalmol Vis Sci 1998; 39(2): 449–54

    PubMed  CAS  Google Scholar 

  6. Francis BA, Du LT, Najafi K, et al. Histopathologic features of conjunctival filtering blebs. Arch Ophthalmol 2005; 123(2): 166–70

    Article  PubMed  Google Scholar 

  7. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003; 48: 314–46

    Article  PubMed  Google Scholar 

  8. Kawase K, Matsushita H, Yamamoto T, et al. Mitomycin concentration in rabbit and human ocular tissues after topical administration. Ophthalmology 1992; 99(2): 203–7

    PubMed  CAS  Google Scholar 

  9. Seah SK, Prata JA, Minckler DS. Mitomycin C concentration in the human ocular tissues following trabeculectomy. Eye 1993; 7: 652–5

    Article  PubMed  Google Scholar 

  10. Costa PV, Spaeth GL, Eiferman RA, et al. Wound healing modulation in glaucoma filtering surgery. Ophthalmic Surg 1993; 24(3): 152–70

    PubMed  CAS  Google Scholar 

  11. Peng TK, Migdal CS. Current techniques in wound healing modulation in glaucoma surgery. Curr Opin Ophthalmol 1996; 7(2): 24–33

    Article  Google Scholar 

  12. Leske MC, Anders H, Hussein M, et al. Factors for glaucoma prevention and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003; 121(1): 48–57

    Article  PubMed  Google Scholar 

  13. Chen CW, Huang HT, Bair JS, et al. Trabeculectomy with simultaneous topical application of mitomycin C in refractory glaucoma. J Ocul Pharmacol 1990; 6: 175–82

    Article  PubMed  Google Scholar 

  14. Kitazawa Y, Suemori-Matsushita H, Yamamoto T, et al. Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma (0.02 vs 0.002). Ophthalmology 1993; 100(11): 1624–8

    PubMed  CAS  Google Scholar 

  15. Spaeth GL, Mutlukan E. The use of antimetabolites with trabeculectomy: a critical appraisal. J Glaucoma 2001; 10(3): 145–51

    Article  PubMed  CAS  Google Scholar 

  16. Joshi AB, Parrish RK, Feuer WF. 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma 2005; 14: 172–4

    Article  PubMed  Google Scholar 

  17. Neelakantan A, Rao BS, Vijaya L, et al. Effect of the concentration and duration of application of mitomycin C in trabeculectomy. Ophthalmic Surg 1994; 25(9): 612–5

    PubMed  CAS  Google Scholar 

  18. Stone RT, Herndon LW, Allingham RR, et al. Results of trabeculectomy with 0.3 mg/ml mitomycin C titrating exposure times based on risk factors for failure. J Glaucoma 1998; 7(1): 39–44

    Article  PubMed  CAS  Google Scholar 

  19. Bindlish R, Condon GP, Schlosser JD, et al. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology 2002; 109(7): 1336–41

    Article  PubMed  Google Scholar 

  20. Casson R, Rahman R, Salmon JF. Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. Br J Ophthalmol 2001; 85(6): 686–8

    Article  PubMed  CAS  Google Scholar 

  21. Cheung JC, Wright MM, Murali S, et al. Intermediate-term outcome of variable dose mitomycin C filtering surgery. Ophthalmology 1997; 104(1): 143–9

    PubMed  CAS  Google Scholar 

  22. Perkins TW, Gangnon R, Ladd W, et al. Trabeculectomy with mitomycin C: intermediate-term results. J Glaucoma 1998; 7(4): 230–6

    Article  PubMed  CAS  Google Scholar 

  23. Akarsu C, Onol M, Hasanreisoglu B. Postoperative 5-fluorouracil versus intraoperative mitomycin C in high-risk glaucoma filtering surgery: extended follow up. Clin Exp Ophthalmol 2003; 31(3): 199–205

    Article  Google Scholar 

  24. Beckers HJ, Kinders KC, Webers CA. Five-year results of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol 2003; 241(2): 106–10

    Article  PubMed  CAS  Google Scholar 

  25. Nuijts RM, Vernimmen RC, Webers CA. Mitomycin C primary trabeculectomy in primary glaucoma of white patients. J Glaucoma 1997; 6: 293–7

    Article  PubMed  CAS  Google Scholar 

  26. Lamping KA, Belkin JK. 5-Flourouracil and mitomycin C in pseudophakic patients. Ophthalmology 1995; 102: 70–5

    PubMed  CAS  Google Scholar 

  27. Casson R, Salmon JF. Combined surgery in the treatment of patients with cataract and primary open angle glaucoma. J Cataract Refract Surg 2001; 27: 1854–63

    Article  PubMed  CAS  Google Scholar 

  28. Carlson DW, Alward WL, Barad JP, et al. A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy. Ophthalmology 1997; 104: 719–24

    PubMed  CAS  Google Scholar 

  29. Cohen JS, Greff LJ, Novack GD, et al. A placebo controlled double masked evaluation of mitomycin C in combined glaucoma and cataract procedures. Ophthalmology 1996; 103: 1934–42

    PubMed  CAS  Google Scholar 

  30. Shin DH, Ren J, Juzych MS, et al. Primary glaucoma triple procedure in patients with primary open angle glaucoma: the effect of mitomycin C in patients with and without prognostic factors for filtration failure. Am J Ophthalmol 1998; 125: 346–52

    Article  PubMed  CAS  Google Scholar 

  31. Shin DH, Iskander NG, Ahee JA, et al. Long-term filtration and visual field outcomes after primary glaucoma triple procedure with and without mitomycin-C. Ophthalmology 2002; 109(9): 1607–11

    Article  PubMed  Google Scholar 

  32. Wilkins M, Indar A, Wormald R. Intraoperative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev 2001; (1): CD002897

  33. Kleinmann G, Katz H, Pollack A, et al. Comparison of trabeculectomy with mitomycin C with or without phaco emulsification and intraocular lens implantation. Ophthalmic Surg Lasers 2002; 33: 102–8

    PubMed  Google Scholar 

  34. Vass C, Menapace R. Surgical Strategies in patients with combined cataract and glaucoma. Curr Opin Ophthalmol 2004; 15: 61–6

    Article  PubMed  CAS  Google Scholar 

  35. Siriwardena D, Kotecha A, Minassian D, et al. Anterior chamber flare after trabeculectomy and after phacoemulsification. Br J Ophthalmol 2000; 84(9): 1056–7

    Article  PubMed  CAS  Google Scholar 

  36. Lochhead J, Casson RJ, Salmon JF. Long term effect on intraocular pressure of phacotrabeculectomy compared to trabeculectomy. Br J Ophthalmol 2003; 87: 850–2

    Article  PubMed  CAS  Google Scholar 

  37. Kosmin AS, Wishart PK, Ridges PJ. Long-term intraocular pressure control after cataract extraction with trabeculectomy: phacoemulsification versus extracapsular technique. J Cataract Refract Surg 1998; 24(2): 249–55

    PubMed  CAS  Google Scholar 

  38. Tezel G, Kolker AE, Kass MA, et al. Comparative results of combined procedures for glaucoma and cataract: I. Extracapsular cataract extraction versus phacoemulsification and foldable versus rigid intraocular lenses. Ophthalmic Surg Lasers 1997; 28(7): 539–50

    CAS  Google Scholar 

  39. al-Hazmi A, Zwaan J, Awad A, et al. Effectiveness and complications of mitomycin C use during pediatric glaucoma surgery. Ophthalmology 1998; 105(10): 1915–20

    Article  PubMed  CAS  Google Scholar 

  40. Mullaney PB, Selleck C, Al-Awad A, et al. Combined trabeculotomy and trabeculectomy as an initial procedure in uncomplicated congenital glaucoma. Arch Ophthalmol 1999; 117(4): 457–60

    Article  PubMed  CAS  Google Scholar 

  41. Mandal AK, Prasad K, Naduvilath TJ. Surgical results and complications of mitomycin C augmented trabeculectomy in refractory developmental glaucoma. Ophthal Surg Lasers 1999; 30: 473–80

    CAS  Google Scholar 

  42. Rodrigues AM, Junior AP, Montezano FT, et al. Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C. J Glaucoma 2004; 13(3): 228–32

    Article  PubMed  Google Scholar 

  43. Al-Hazmi A, Awad A, Zwaan J, et al. Correlation between surgical success rate and severity of congenital glaucoma. Br J Ophthalmol 2005; 89(4): 449–53

    Article  PubMed  CAS  Google Scholar 

  44. Mandal AK, Walton DS, John T, et al. Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma. Ophthalmology 1997; 104(6): 996–1001

    PubMed  CAS  Google Scholar 

  45. Cantor L, Burgoyne J, Sanders S, et al. The effect of mitomycin C on Molteno implant surgery. J Glaucoma 1998; 7: 240–6

    Article  PubMed  CAS  Google Scholar 

  46. Perkins TW, Gangnon R, Ladd W, et al. Molteno implant with mitomycin C: intermediate term results. J Glaucoma 1998; 7: 86–92

    PubMed  CAS  Google Scholar 

  47. Azuara-Blanco A, Moster MR, Wilson RP, et al. Simultaneous use of mitomycin C with Baerveldt implantation. Ophthalmic Surg Lasers 1997; 28: 992–7

    PubMed  CAS  Google Scholar 

  48. Lee D, Flores RA, Anderson PJ, et al. The effect of adjunctive mitomycin C in Molteno implant surgery. Ophthalmology 1997; 104: 2126–35

    PubMed  CAS  Google Scholar 

  49. Costa VP, Azuora-Blanca A, Netland PA, et al. Efficacy and safety of adjunctive mitomycin C during Ahmed glaucoma valve implantation: a prospective randomized clinical trial. Ophthalmology 2004; 111(6): 1071–6

    Article  PubMed  Google Scholar 

  50. Mardelli PG, Lederer CM, Murray PL, et al. Slit-lamp needle revision of failed filtering blebs using mitomycin C. Ophthalmology 1996; 103(11): 1946–55

    PubMed  CAS  Google Scholar 

  51. Iwach AG, Delgado MF, Novack GD, et al. Transconjunctival mitomycin-C in needle revisions of failing filtering blebs. Ophthalmology 2003; 110(4): 734–42

    Article  PubMed  Google Scholar 

  52. Shetty RK, Wartluft L, Moster MR. Slit-lamp needle revision of failed filtering blebs using high-dose mitomycin C. J Glaucoma 2005; 14(1): 52–6

    Article  PubMed  Google Scholar 

  53. Jaros PA, De Luise VP. Pingueculae and pterygia. Surv Ophthalmol 1988; 33: 41–9

    Article  PubMed  CAS  Google Scholar 

  54. Saw SM, Banerjee K, Tan D. Risk factors for the development of pterygium in Singapore: a hospital-based case-control study. Acta Ophthalmol Scand 2000; 78: 216–20

    Article  PubMed  CAS  Google Scholar 

  55. Saw SM, Tan D. Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol 1999; 6: 219–28

    Article  PubMed  CAS  Google Scholar 

  56. McCarty CA, Fu CL, Taylor HR. Epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol 2000; 84: 289–92

    Article  PubMed  CAS  Google Scholar 

  57. Kwok LS, Coroneo MT. A model for pterygium formation. Cornea 1994; 13(3): 219–24

    Article  PubMed  CAS  Google Scholar 

  58. Dion E. The treatment of pterygium. Ophthalmic Surg 1977; 8: 12–30

    Google Scholar 

  59. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 1985; 92: 1461–70

    PubMed  CAS  Google Scholar 

  60. Shaw EL. A modified technique for conjunctival transplant. CLAO J 1992; 18: 112–6

    PubMed  CAS  Google Scholar 

  61. Lewallen S. A randomized controlled trial of conjunctival autografting for pterygium in the tropics. Ophthalmology 1989; 96: 1612–4

    PubMed  CAS  Google Scholar 

  62. Chen PP, Ariyasu RG, Kaza V, et al. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol 1995; 120: 151–60

    PubMed  CAS  Google Scholar 

  63. Ma DH, See LC, Hwang YS, et al. Comparison of amniotic membrane graft alone or combined with intraoperative mitomycin C to prevent recurrence after excision of recurrent pterygia. Cornea 2005; 24(2): 141–50

    Article  PubMed  Google Scholar 

  64. Essex RW, Snibson GR, Daniell M, et al. Amniotic membrane grafting in the surgical management of primary pterygium. Clin Exp Ophthalmol 2004; 32(5): 501–4

    Article  Google Scholar 

  65. Basti S, Rao SK. Current status of limbal conjunctival autograft. Curr Opin Ophthalmol 2000; 11(4): 224–32

    Article  PubMed  CAS  Google Scholar 

  66. Hayasaka S, Noda S, Yamamoto Y, et al. Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol 1988; 106(6): 715–8

    PubMed  CAS  Google Scholar 

  67. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988; 95: 813–21

    PubMed  CAS  Google Scholar 

  68. Fujitani A, Hayasaka S, Shibuya Y, et al. Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy. Ophthalmologica 1993; 207(3): 162–4

    Article  PubMed  CAS  Google Scholar 

  69. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992; 99(11): 1647–54

    PubMed  CAS  Google Scholar 

  70. Frucht-Pery J, Ilsar M. The use of low-dose mitomycin C for prevention of recurrent pterygium. Ophthalmology 1994; 101(4): 759–62

    PubMed  CAS  Google Scholar 

  71. Frucht-Pery J, Ilsar M, Hemo I. Single dosage of mitomycin C for prevention of recurrent pterygium: preliminary report. Cornea 1994; 13(5): 411–3

    Article  PubMed  CAS  Google Scholar 

  72. Frucht-Pery J, Siganos CS, Ilsar M. Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology 1996; 103(4): 674–7

    PubMed  CAS  Google Scholar 

  73. Caliskan S, Orhan M, Irkec M. Intraoperative and postoperative use of mitomycin-C in the treatment of primary pterygium. Ophthalmic Surg Lasers 1996; 27(7): 600–4

    PubMed  CAS  Google Scholar 

  74. Cardillo JA, Alves MR, Ambrosio LE, et al. Single intraoperative application versus post operative mitomycin C eye drops in pterygium surgery. Ophthalmology 1995; 102: 1949–52

    PubMed  CAS  Google Scholar 

  75. Manning CA, Kloess PM, Diaz MD, et al. Intraoperative mitomycin in primary pterygium excision: a prospective randomized trial. Ophthalmology 1997; 108: 844–8

    Google Scholar 

  76. Lam DS, Wong AK, Fan DS, et al. Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30 month follow up study. Ophthalmology 1998; 105: 901–4

    Article  PubMed  CAS  Google Scholar 

  77. Cheng HC, Tseng SH, Kao PL, et al. Low-dose intraoperative mitomycin C as chemoadjuvant for pterygium surgery. Cornea 2001; 20(1): 24–9

    Article  PubMed  CAS  Google Scholar 

  78. Donnenfeld ED, Perry HD, Fromer S, et al. Subconjunctival mitomycin C as adjunctive therapy before pterygium excision. Ophthalmology 2003; 110: 1012–26

    Article  PubMed  Google Scholar 

  79. Raiskup F, Solomon A, Landau D, et al. Mitomycin C for pterygium: long term evaluation. Br J Ophthalmol 2004; 88: 1425–8

    Article  PubMed  CAS  Google Scholar 

  80. Murakami M, Mori S, Kunitomo N. Studies on the pterygium: V. Follow-up information of mitomycin C treatment. Nippon Ganka Gakkai Zasshi 1967; 71(4): 351–8

    CAS  Google Scholar 

  81. Young AL, Leung GYS, Wong AKK, et al. A randomized trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium. Br J Ophthalmol 2004; 88: 995–7

    Article  PubMed  CAS  Google Scholar 

  82. Segev F, Jaeger-Roshu S, Gefen-Carmi N, et al. Combined mitomycin C application and free flap conjunctival autograft in pterygium surgery. Cornea 2003; 22: 598–603

    Article  PubMed  Google Scholar 

  83. Toti A. Nuovo metodo conservatore di cura radicale delle suporazioni chroniche del sacco lacrimale. Clin Mod Firenze 1904; 10: 385–9

    Google Scholar 

  84. Dupuy-Dutemps L, Bourguet J. Procède plastique de dacryocystorhinostomie et ses resultats. Ann Ocul (Paris) 1921; 158: 241–61

    Google Scholar 

  85. Iliff CE. A simplified dacryocystorhinostomy. Arch Ophthalmol 1971; 85: 586–91

    Article  PubMed  CAS  Google Scholar 

  86. Pico G. A modified technique of external dacryocystorhinostomy. Am J Ophthalmol 1971; 72: 679–89

    PubMed  CAS  Google Scholar 

  87. Tarbet KJ, Custer PL. External dacryocystorhinostomy: surgical success, patient satisfaction, and economic cost. Ophthalmology 1995; 102: 1065–70

    PubMed  CAS  Google Scholar 

  88. Welham RAN, Wulc AE. Management of unsuccessful lacrimal surgery. Br J Ophthalmol 1987; 71: 152–7

    Article  PubMed  CAS  Google Scholar 

  89. Walland MJ, Rose GE. Factors affecting the success rate of open lacrimal surgery. Br J Ophthalmol 1994; 78: 888–91

    Article  PubMed  CAS  Google Scholar 

  90. Liao SL, Kao SC, Tseng JH, et al. Results of intraoperative mitomycin C application in dacryocystorhinostomy. Br J Ophthalmol 2000; 84(8): 903–6

    Article  PubMed  CAS  Google Scholar 

  91. Linberg JV, Anderson RL, Bumsted RM, et al. Study of intranasal ostium external dacryocystorhinostomy. Arch Ophthalmol 1982; 100: 1758–62

    Article  PubMed  CAS  Google Scholar 

  92. Kao SC, Liao CL, Tseng JH, et al. Dacryocystorhinostomy with intraoperative mitomycin C. Ophthalmology 1997; 104(1): 86–91

    PubMed  CAS  Google Scholar 

  93. You YA, Fang CT. Intraoperative mitomycin C in dacryocystorhinostomy. Ophthal Plast Reconstr Surg 2001; 17(2): 115–9

    Article  PubMed  CAS  Google Scholar 

  94. Roozitalab MH, Amirahmadi M, Namazi MR. Results of the application of intraoperative mitomycin C in dacryocystorhinostomy. Eur J Ophthalmol 2004; 14(6): 461–3

    PubMed  CAS  Google Scholar 

  95. Yeatts RP, Neves RB. Use of mitomycin C in repeat dacryocystorhinostomy. Ophthal Plast Reconstr Surg 1999; 15(1): 19–22

    Article  PubMed  CAS  Google Scholar 

  96. Zilelioglu G, Ugurbas SH, Anadolu Y, et al. Adjunctive use of mitomycin C on endoscopic lacrimal surgery. Br J Ophthalmol 1998; 82(1): 63–6

    Article  PubMed  CAS  Google Scholar 

  97. Camara JG, Bengzon AU, Henson RD. The safety and efficacy of mitomycin C in endonasal endoscopic laser-assisted dacryocystorhinostomy. Ophthal Plast Reconstr Surg 2000; 16(2): 114–8

    Article  PubMed  CAS  Google Scholar 

  98. Kaufman LM, Guay-Bhatia LA. Monocanalicular intubation with Monoka tubes for the treatment of congenital nasolacrimal duct obstruction. Ophthalmology 1998; 105(2): 336–41

    Article  PubMed  CAS  Google Scholar 

  99. Fulcher T, O’Connor M, Moriarty P. Nasolacrimal intubation in adults. Br J Ophthalmol 1998; 82(9): 1039–41

    Article  PubMed  CAS  Google Scholar 

  100. Liu D, Bosley TM. Silicone nasolacrimal intubation with mitomycin C: a prospective randomized, double masked study. Ophthalmology 2003; 110: 306–10

    Article  PubMed  Google Scholar 

  101. Lam S, Tessler HH. Mitomycin as adjunct therapy in correcting iatrogenic punctal stenosis. Ophthalmic Surg 1993; 24(2): 123–4

    PubMed  CAS  Google Scholar 

  102. Ma’luf RN, Hamush NG, Awwad ST, et al. Mitomycin C as adjunct therapy in correcting punctal stenosis. Ophthal Plast Reconstr Surg 2002; 18(4): 285–8

    Article  PubMed  Google Scholar 

  103. Gartry DS, Kerr Muir MG, Marshall J. Excimer laser photorefractive keratectomy: 18 month follow up. Ophthalmology 1992; 99: 1209–19

    PubMed  CAS  Google Scholar 

  104. Lee YC, Hu FR, Wang IJ. Quality of vision after laser in situ keratomileusis: influence of diopteric correction and pupil size on visual function. J Cataract Refract Surg 2003; 29: 769–77

    Article  PubMed  Google Scholar 

  105. Gartry DS, Kerr Muir MG, Marshall J. The effect of topical corticosteroids on refraction and corneal haze following excimer laser treatment of myopia: an update. A prospective, randomised, double-masked study. Eye 1993; 7: 584–90

    Google Scholar 

  106. O’Brart DP, Lohmann CP, Klonos G, et al. The effects of topical corticosteroids and plasmin inhibitors on refractive outcome, haze, and visual performance after photorefractive keratectomy: a prospective, randomized, observer-masked study. Ophthalmology 1994; 101(9): 1565–74

    PubMed  Google Scholar 

  107. Arshinoff S, D’Addario D, Sadler C, et al. Use of topical nonsteroidal anti-inflammatory drugs in excimer laser photorefractive keratectomy. J Cataract Refract Surg 1994; Suppl.: 216–22

  108. Talamo GH, Gollamudi S, Green WR, et al. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol 1991; 109: 1141–6

    Article  PubMed  CAS  Google Scholar 

  109. Schipper I, Suppelt C, Gebbers JO. Mitomycin C reduces scar formation after excimer laser (193 nm) photorefractive keratectomy in rabbits. Eye 1997; 11: 649–55

    Article  PubMed  Google Scholar 

  110. Xu H, Liu S, Xia X, et al. Mitomycin C reduces haze formation in rabbits after excimer laser photorefractive keratectomy. J Refract Surg 2001; 17(3): 342–9

    PubMed  CAS  Google Scholar 

  111. Majmudar PA, Forstet SL, Dennis RF, et al. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 2000; 107(1): 89–94

    Article  PubMed  CAS  Google Scholar 

  112. Carones F, Vigo L, Scandola E, et al. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy. J Cataract Refract Surg 2002; 28(12): 2088–95

    Article  PubMed  Google Scholar 

  113. Gambato C, Ghirlando A, Moretto E, et al. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology 2005; 112(2): 208–18

    Article  PubMed  Google Scholar 

  114. Chalita MR, Roth AS, Krueger RR. Wavefront-guided surface ablation with prophylactic use of mitomycin C after a button-hole laser in situ keratomileusis flap. J Refract Surg 2004; 20(2): 176–81

    PubMed  Google Scholar 

  115. Muller LT, Candal EM, Epstein RJ, et al. Transepithelial phototherapeutic keratectomy/photorefractive keratectomy with adjunctive mitomycin-C for complicated LASIK flaps. J Cataract Refract Surg 2005; 31(2): 291–6

    Article  PubMed  Google Scholar 

  116. Eschele-Meniconi ME, Ahmad SR, Foster CS. Mucous membrane pemphigoid: an update. Curr Opin Ophthalmol 2005; 16(5): 303–7

    Article  Google Scholar 

  117. Donnenfeld ED, Perry HD, Wallerstein A, et al. Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid. Ophthalmology 1999; 106(1): 72–8

    Article  PubMed  CAS  Google Scholar 

  118. Celis Sanchez J, Lopez Ferrando N, Garcia Largacha M, et al. Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid. Arch Soc Esp Oftalmol 2002; 77(9): 501–6

    PubMed  CAS  Google Scholar 

  119. Solomon A, Espana EM, Tseng SC. Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology 2003; 110: 93–100

    Article  PubMed  Google Scholar 

  120. Secchi AG, Tognon MS. Intraoperative mitomycin C in the treatment of cicatricial obliterations of conjunctival fornices. Am J Ophthalmol 1996; 122(5): 728–30

    PubMed  CAS  Google Scholar 

  121. Tseng SC, Di Pascuale MA, Liu DT, et al. Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases. Ophthalmology 2005; 112(5): 896–903

    Article  PubMed  Google Scholar 

  122. Majumdar PA, Epstein RJ. Antimetabolites in ocular surface neoplasia. Curr Opin Ophthalmol 1998; 9: 35–9

    Article  Google Scholar 

  123. Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors: the 1994 Lynn B McMahan Lecture. Arch Ophthalmol 1997; 115(6): 808–15

    Article  PubMed  CAS  Google Scholar 

  124. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol 1995; 39(6): 429–50

    Article  PubMed  CAS  Google Scholar 

  125. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 1994; 117(2): 164–8

    PubMed  CAS  Google Scholar 

  126. Wilson MW, Hungerford JL, George SM, et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol 1997; 124(3): 303–11

    PubMed  CAS  Google Scholar 

  127. Heigle TJ, Stalling RD, Palay DA. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol 1997; 124(3): 397–9

    PubMed  CAS  Google Scholar 

  128. Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology 1997; 104(12): 2085–93

    PubMed  CAS  Google Scholar 

  129. Rozenman Y, Frucht-Pery J. Treatment of conjunctival intraepithelial neoplasia with topical drops of mitomycin C. Cornea 2000; 19(1): 1–6

    Article  PubMed  CAS  Google Scholar 

  130. Akpek EK, Ertoy D, Kalayci D, et al. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia. Cornea 1999; 18(1): 59–62

    Article  PubMed  CAS  Google Scholar 

  131. Siganos CS, Kozobolis VP, Christodoulakis EV. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation. Cornea 2002; 21(1): 12–6

    Article  PubMed  Google Scholar 

  132. Yamamoto N, Ohmura T, Suzuki H, et al. Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C. Ophthalmology 2002; 109(2): 249–52

    Article  PubMed  Google Scholar 

  133. Di Pascuale MA, Espana EM, Tseng SC. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles. Cornea 2004; 23(1): 89–92

    Article  PubMed  Google Scholar 

  134. Kemp EG, Harnett AN, Chatterjee S. Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias. Br J Ophthalmol 2002; 86(1): 31–4

    Article  PubMed  CAS  Google Scholar 

  135. Chen C, Louis D, Dodd T, et al. Mitomycin C as an adjunct in the treatment of localized ocular surface squamous neoplasia. Br J Ophthalmol 2004; 88(1): 17–8

    Article  PubMed  CAS  Google Scholar 

  136. Prabhasawat P, Tarinvorakup P, Tesavibul N, et al. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea 2005; 24(4): 443–8

    Article  PubMed  Google Scholar 

  137. Corcoran KT, Marsich MM, Ward DC. Potentially life threatening primary acquired melanosis. Clin Eye Vis Care 2000; 12: 185–8

    Article  PubMed  Google Scholar 

  138. Folberg R, McLean IW, Zimmerman LE. Conjunctival melanosis and melanoma. Ophthalmology 1984; 91: 673–8

    PubMed  CAS  Google Scholar 

  139. Norregaard JC, Gerner N, Jensen OA, et al. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol 1996; 234: 569–72

    Article  PubMed  CAS  Google Scholar 

  140. Frucht-Pery J, Pe’er J. Use of mitomycin C in the treatment for conjunctival primary acquired melanosis with atypia. Arch Ophthalmol 1996; 114: 1261–4

    Article  PubMed  CAS  Google Scholar 

  141. Pe’er J, Frucht-Pery J. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C. Am J Ophthalmol 2005; 139(2): 229–34

    Article  PubMed  Google Scholar 

  142. Seregard S. Conjunctival Melanoma. Surv Ophthalmol 1998; 42: 321–50

    Article  PubMed  CAS  Google Scholar 

  143. Shields JA, Shields CL, De Potter P. Surgical management of circumscribed conjunctival melanomas. Ophthal Plastic Reconstr Surg 1998; 14: 208–15

    Article  CAS  Google Scholar 

  144. Jakobiec FA, Brownstein S, Wilkinson RD, et al. Combined surgery and cryotherapy for diffuse malignant melanoma of the conjunctiva. Arch Ophthalmol 1980; 98: 1390–6

    Article  PubMed  CAS  Google Scholar 

  145. Werschnik C, Lommatzsch PK. Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol 2002; 25(3): 248–55

    Article  PubMed  Google Scholar 

  146. Wilson MW, Schelonka LP, Siegel D, et al. Immunohistochemical localization of NAD(P)H:quinone oxidoreductase in conjunctival melanomas and primary acquired melanosis. Curr Eye Res 2001; 22(5): 348–52

    Article  PubMed  CAS  Google Scholar 

  147. Demirci H, McCormick SA, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. Arch Ophthalmol 2000; 118(7): 885–91

    PubMed  CAS  Google Scholar 

  148. Greenfield DS, Leibmann JM, Suner IJ, et al. Late onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol 1998; 116: 443–7

    PubMed  CAS  Google Scholar 

  149. Greenfield DS, Suner IJ, Miller MP. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 1996; 114(8): 943–9

    Article  PubMed  CAS  Google Scholar 

  150. Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 1996; 15(5): 537–40

    Article  PubMed  CAS  Google Scholar 

  151. Smith S, D’Amore PA, Dreyer FB. Comparative toxicity of mitomycin C and 5-fluorouracil in vitro. Am J Ophthalmol 1994 15; 118(3): 332–7

    PubMed  CAS  Google Scholar 

  152. Scott IU, Cruz-Villegas V, Flynn HW, et al. Delayed-onset, bleb-associated endophthalmitis caused by Lecythophora mutabilis. Am J Ophthalmol 2004; 137(3): 583–5

    Article  PubMed  Google Scholar 

  153. Song A, Scott IU, Flynn HW, et al. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology 2002; 109(5): 985–91

    Article  PubMed  Google Scholar 

  154. Hsiao CH, Chen JJ, Huang SC, et al. Intrascleral dissemination of infectious scleritis following pterygium excision. Br J Ophthalmol 1998; 82(1): 29–34

    Article  PubMed  CAS  Google Scholar 

  155. Singh RP, McCulskey P. Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C. Clin Experiment Ophthalmol 2005; 33(4): 433–4

    Article  PubMed  Google Scholar 

  156. Dudney BW, Malecha MA. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. Am J Ophthalmol 2004; 137(5): 950–1

    Article  PubMed  Google Scholar 

  157. Billing K, Karagiannis A, Selva D. Punctal-canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia. Am J Ophthalmol 2003; 136(4): 746–7

    Article  PubMed  Google Scholar 

  158. Salomao DR, Mathers WD, Sutphin JE, et al. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy. Ophthalmology 1999; 106(9): 1756–60

    Article  PubMed  CAS  Google Scholar 

  159. Sacu S, Segur-Eltz N, Horvat R, et al. Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. Am J Ophthalmol 2003; 136(2): 375–7

    Article  PubMed  Google Scholar 

  160. Cruz OA, Matkovich L. Effects of intraoperative topical mitomycin-C on strabismus surgery in the rabbit: a preliminary study. Ophthalmic Surg 1995; 26(3): 237–40

    PubMed  CAS  Google Scholar 

  161. Mahindrakar A, Tandon R, Menon V, et al. Effectiveness of mitomycin C in reducing reformation of adhesions following surgery for restrictive strabismus. J Pediatr Ophthalmol Strabismus 2001; 3(3): 131–5

    Google Scholar 

  162. Edelstein C, Shields CL, De Potter P, et al. Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology 1997; 104(10): 1616–21

    PubMed  CAS  Google Scholar 

  163. Lew H, Lee SY, Yang WI, et al. A morphological study of drill holes applied with mitomycin-C in hydroxyapatite orbital implants. Ophthal Res 2001; 33(6): 340–4

    Article  CAS  Google Scholar 

  164. Wu WC, Kao YH, Hu DN. A comparative study of effects of antiproliferative drugs on human retinal pigment epithelial cells in vitro. J Ocul Pharmacol Ther 2002; 18(3): 251–64

    Article  PubMed  CAS  Google Scholar 

  165. Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1993; 11: 632–5

    Article  Google Scholar 

  166. Spoor TC, McHenry JG, Shin DH. Long-term results using adjunctive mitomycin C in optic nerve sheath decompression for pseudotumor cerebri. Ophthalmology 1995; 102: 2024–8

    PubMed  CAS  Google Scholar 

  167. Mietz H, Prager TC, Schweitzer C, et al. Effect of mitomycin C on the optic nerve in rabbits. Br J Ophthalmol 1997; 81(7): 584–859

    Article  PubMed  CAS  Google Scholar 

  168. Haus CM, Galand AL. Mitomycin against posterior capsular opacification: an experimental study in rabbits. Br J Ophthalmol 1996; 80(12): 1087–91

    Article  PubMed  CAS  Google Scholar 

  169. Shin DH, Kim YY, Ren J, et al. Decrease of capsular opacification with adjunctive mitomycin C in combined glaucoma and cataract surgery. Ophthalmology 1998; 105(7): 1222–6

    Article  PubMed  CAS  Google Scholar 

  170. Akpek EK, Hasiripi H, Christen WG, et al. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis. Ophthalmology 2000; 107(2): 263–9

    Article  PubMed  CAS  Google Scholar 

  171. Sodhi PK, Pandey RM, Ratan SK. Efficacy and safety of topical azelastine compared with topical mitomycin C in patients with allergic conjunctivitis. Cornea 2003; 22(3): 210–3

    Article  PubMed  Google Scholar 

  172. Tanaka M, Takano Y, Dogru M, et al. A comparative evaluation of the efficacy of intraoperative mitomycin C use after the excision of cobblestone-like papillae in severe atopic and vernal keratoconjunctivitis. Cornea 2004; 23(4): 326–9

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

No sources of funding were used in the preparation of this manuscript. The authors have no potential conflicts of interest directly related to the contents of this article.

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Sciences, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia

    Lekha M. Abraham, Dinesh Selva, Robert Casson &  Igal Leibovitch

  2. Departments of Medicine and Surgery, University of Adelaide, Adelaide, South Australia, Australia

    Dinesh Selva

Authors
  1. Lekha M. Abraham
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Dinesh Selva
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Robert Casson
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Igal Leibovitch
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Igal Leibovitch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abraham, L.M., Selva, D., Casson, R. et al. Mitomycin. Drugs 66, 321–340 (2006). https://doi.org/10.2165/00003495-200666030-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200666030-00005

Keywords